Skip to content
Monday, November 16, 2026
Discover insights on space exploration, technology trends, …

Zimbabwe Declines ‘Unbalanced’ US Healthcare Assistance Deal Over Information Apprehensions

Medical aid image
The offered American funding would have supported initiatives for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

The nation of Zimbabwe has turned down a major American healthcare agreement worth 367 million US dollars (£272m) over five years over Washington's demand for confidential data.

This move came to light following a official document from December was leaked, which showed President Emmerson Mnangagwa believed the arrangement was "unbalanced".

An official spokesman later explained that the US was requesting health data for scientific study and commercial purposes but was not willing to share the benefits from any future treatments.

"We must now begin the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the United States had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has called for continued talks to find a agreement suitable to all parties so the nation's critical HIV programme can continue.

Broader Context

Zimbabwe's decision follows a similar situation in neighbouring Kenya, where a high court suspended a related deal with the US following concerns were raised about the safety of citizens' medical information.

Since resuming office last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).

USAID had overseen aid for the US government, but Trump argued its spending was "wasteful" and his administration was seeking government-to-government agreements to enhance openness and responsibility.

Based on statements, 16 African countries have to date agreed to similar health pacts, representing over $18.3bn of fresh investment.

Specifics of the Rejected Deal

The money for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this partnership might have yielded extraordinary benefits for Zimbabwean communities, especially the 1.2 million currently receiving antiretroviral therapy via American-funded initiatives," Tremont added.

However, official spokesman Nick Mangwana said the proposed deal was "unfair".

"The proposal required Zimbabwe to provide its biological resources and data for a long time, without any equivalent promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," he stated.

"In essence, our nation would provide the raw materials for scientific discovery with no assurance that the end products would be available to our population should a new disease outbreak arise."

Sovereignty and Global Health

Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending systems already set up via the international organization.

The spokesperson cited its Pandemic Benefit-Sharing scheme created to manage future global health emergencies.

"This framework is intended to ensure that when a nation provides its information, the benefits – such as medicines and cures – are shared equitably, not monopolised solely by those with the resources to create them."

These objections regarding the US deal "are not meant as anti-American sentiment," he added.

"We welcome continued dialogue with our American counterparts on how future co-operation could be arranged in a way that respects the independence and dignity of both nations."

Health Experts Response

Medical experts said it recognised the official position, but urged that negotiations should continue considering a large portion of the country's HIV programmes relied on foreign aid.

"If specific concerns exist, including those relating to data governance or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," it added.

The situation highlights the complex tensions between accepting crucial international aid and protecting local interests in an increasingly interconnected world.

Written by

Jason Carroll

A space technology journalist with a background in astrophysics, passionate about making complex cosmic concepts accessible to everyone.

Orbitland

Type to search articles.